Express Investigations

Top Categories

Express Investigations, India

Bureaucratic hurdles and a hefty Rs 10 lakh prepayment: India’s cancer patients face barriers to accessing top-selling medication.

April 14, 2026
Express Investigations, India

Priced at ₹1.5 lakh per dose, ‘miracle’ cancer medication exposed as counterfeit, with fraudulent versions reaching vulnerable patients from leading hospitals.

April 13, 2026
Express Investigations, India

Merck & Co addresses Keytruda packaging disclosure: ‘Healthcare providers accountable for discarded materials’

April 13, 2026